Breaking: Pfizer in hot pursuit of a $5B buyout of Global Blood Therapeutics — report - Endpoints News

Pfizer CEO Albert Bourla has vowed to leave no stone unturned in the search for new biotech deals, and the BD team is not letting him down. The Wall Street Journal reported today that Pfizer is in the final stages of acquiring Global Blood Therapeutics for $5…

A federal appeals court on Tuesday denied prosecutors’ attempt to lengthen the sentences of two former GSK scientists who pleaded guilty to stealing trade secrets. Yu Xue and Tao Li pleaded guilty b… [+625 chars]

full article...